Tavr was / is only for older patients... at this stage...
Again note that the intent of the AHZ device is to be able to offer to younger patients because of its durability hence the market size potential increases in size to about $7.5b which the admedus device if successful may take the lions share as it has such amazing durability characteristics already.
Another boom moment!
Getting bigger by the day so hold tight fellow share holders.
People might not have done their research so don't lose faith over a share price that's being played. The next announcement may just be the co-development deal we are expecting. When that happens, we are on the home stretch to massive growth and profits some of you wouldn't believe or imagine.
Dyor and gltah
Ann: Admedus update on TAVR project, page-11
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
-0.800(5.71%) |
Mkt cap ! $279.0M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.00 | $13.11 | $947.2K | 71.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |